Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

Russo F;Galluzzo M;Stingeni L;Persechino S;Zichichi L;Conti A;Giofrè C;Dini V;Vispi M;Atzori L;Cattaneo A;Parodi A;Bardazzi F;Stinco G;Dapavo P;Girolomoni G;Musumeci ML;Papini M;Venturini M

Writing – Review & Editing

;Dastoli S;Di Nuzzo S;Fargnoli MC;Pagnanelli G;Bernardini N;Gambini DM;Malagoli P;Mazzatenta C;Peris K;Zalaudek I;Fabbrocini G;Loconsole F;Vassallo C;Pietroleonardo L;Prignano F;Franchi C;Offidani AM;Bonifati C;Di Lernia V;Gigante G;Bartezaghi MS;Franchi M;Ursoleo P;Aloisi E.

2023-01-01